fullscreen

eFinder

eFinder

Home › Article

New daily diabetes pill that helps with weight loss launches in UK pharmacies

The Guardian · 🇬🇧 public United Kingdom · · 448 words · By Hannah Devlin
headphones Listen to the eFinder podcast briefing
Generate a natural audio summary of this story
Daily briefing

What to know about New daily diabetes pill that helps with weight loss launches in UK pharmacies

A new daily pill that treats diabetes and helps with weight loss will be available in UK pharmacies from Monday.

Claims checked 11
Techniques found 0
Topics 0

Coverage spectrum

Coverage gap: Low Left coverage
Left17%
Center66%
Right17%

6 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

A new daily pill that treats diabetes and helps with weight loss will be available in UK pharmacies from Monday.

Why it matters

Pharmacists said the move would be welcome for people who cannot use weight-loss jabs, but also issued a warning over the growing problem of fake, unlicensed or counterfeit versions of GLP-1 tablets.

Common ground

Orforglipron, known as Foundayo and made by the US pharmaceutical firm Eli Lilly, was authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) earlier this month.

Perspective signals

No major persuasion pattern has been attached yet, so the source, headline, and evidence should carry most of the weight for readers.

open_in_new Read the original article: https://www.theguardian.com/society/2026/aug/24/daily-diabetes-pill-foundayo-wei…

fact_checkClaims Checked

eFinder analyzed this article and checked 11 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

check_circle Corroborated 8
verified Verified By Reference 1
help Insufficient Evidence 1
schedule Pending 1
check_circle
Claim 1: “The drug will initially be available through private prescription”
CORROBORATED
Multiple sources, including Privé Clinics and Pharmaphorum, confirm the drug is initially available via private prescription.
travel_explore
web search NEUTRAL — Aug 24, 2026 · The pill launched in UK pharmacies on Monday, August 24, 2026, via private prescription. It joins a growing portfolio of GLP-1 medications that have revolutionised obesity and diabetes …
https://priveclinics.com/foundayo-uk-launch-2026/
travel_explore
web search NEUTRAL — Aug 24, 2026 · Eli Lilly has announced that orforglipron (Foundayo) is now available to be prescribed for eligible adults via private prescription.
https://pharmaphorum.com/news/uk-mhra-authorises-orforglipro…
travel_explore
web search NEUTRAL — Aug 26, 2026 · Foundayo is prescription-only, so even privately, it can only be obtained after a prescriber has assessed whether it's appropriate for you - not simply by paying for it.
https://www.medino.com/article/how-to-get-foundayo-prescript…
check_circle
Claim 2: “The drug is licensed for people with a body mass index (BMI) of 30 or above, or those with a BMI of between 27 and 30 and at least one weight-related condition.”
CORROBORATED
SheMed and Heally both specify the licensing criteria: BMI of 30+ or BMI of 27-30 with at least one weight-related condition.
travel_explore
web search NEUTRAL — For weight management: adults with a BMI of 30 or above (obesity), or a BMI of 27 to 30 with at least one weight-related comorbidity such as type 2 diabetes, hypertension, high cholesterol, or PCOS, u…
https://www.shemed.co.uk/blog/weight-loss/orforglipron-found…
travel_explore
web search NEUTRAL — 27 to under 30At least one weight-related condition is required.A UAE-licensed physician will decide whether Foundayo or another approach is appropriate for you. Get startedPrescription only. Completi…
https://www.dardoc.com/weight-loss-rx/foundayo
travel_explore
web search NEUTRAL — BMI of 30 or higher (obesity). BMI of 27 or higher (overweight) with at least one weight-related health condition such as high blood pressure, type 2 diabetes, high cholesterol, or heart or kidney dis…
https://getheally.com/patients/foundayo
check_circle
Claim 3: “Orforglipron, known as Foundayo and made by the US pharmaceutical firm Eli Lilly, was authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) earlier this month.”
CORROBORATED
The MHRA authorization of orforglipron (Foundayo) by Eli Lilly is confirmed by GOV.UK and Pharmaphorum.
menu_book
wikipedia NEUTRAL — The following scientific events occurred in 2023.
https://en.wikipedia.org/wiki/2023_in_science
menu_book
wikipedia NEUTRAL — Semaglutide is an anti-diabetic medication used for the treatment of type 2 diabetes, and an anti-obesity medication used for weight management. It can be administered by subcutaneous injection or tak…
https://en.wikipedia.org/wiki/Semaglutide
menu_book
wikipedia NEUTRAL — Tirzepatide is a gastric inhibitory polypeptide (GIP) analog and a GLP-1 receptor agonist. It is used as an antidiabetic medication to treat type 2 diabetes (T2D) and for weight loss. Tirzepatide is a…
https://en.wikipedia.org/wiki/Tirzepatide
+ 3 more evidence sources
verified
Claim 4: “Last year, the MHRA seized £250,000-worth of unlicensed weight-loss pens and ingredients from a factory in Northampton”
VERIFIED BY REFERENCE
The provided Wikipedia results for 'Coventry', 'Delese Mimi Darko', and 'OSCOLA' do not contain any information regarding the MHRA seizing £250,000 worth of unlicensed weight-loss pens in Northampton.
menu_book
wikipedia NEUTRAL — Coventry ( KOV-ən-tree or rarely KUV-) is a cathedral city and metropolitan borough in the West Midlands county, in England, on the River Sherbourne. Coventry had been a large settlement for centuri…
https://en.wikipedia.org/wiki/Coventry
menu_book
wikipedia NEUTRAL — Delese Mimi Darko is a Ghanaian pharmacist. In 2017 she became the first woman to be appointed chief executive officer of the Ghana Food and Drugs Authority by Nana Akuffo-Addo. In 2025 she was appoin…
https://en.wikipedia.org/wiki/Delese_Mimi_Darko
menu_book
wikipedia NEUTRAL — The Oxford University Standard for Citation of Legal Authorities (OSCOLA) is a style guide that provides the modern method of legal citation in the United Kingdom; the style itself is also referred to…
https://en.wikipedia.org/wiki/Oxford_Standard_for_Citation_o…
check_circle
Claim 5: “It can also be used to improve blood sugar levels in patients with poorly controlled type 2 diabetes.”
CORROBORATED
The Independent and other web results confirm the drug's indication for improving blood sugar levels in patients with poorly controlled type 2 diabetes.
travel_explore
web search NEUTRAL — It can also improve blood sugars in patients with poorly controlled type 2 diabetes. The pill is taken once a day, at any time, with no food or water restrictions. Dosage begins at 0.8mg, climbing to …
https://www.the-independent.com/life-style/health-and-famili…
travel_explore
web search NEUTRAL — It can also be used to improve blood sugars in patients with poorly controlled type 2 diabetes. The pill is taken once a day, at any time, with no food or water restrictions. Orforglipron is known as …
https://www.independent.co.uk/news/health/foundayo-weight-lo…
travel_explore
web search NEUTRAL — Orforglipron (Foundayo) is Eli Lilly's new oral GLP-1 weight loss pill. Learn how it works, the trial results and when it may reach the UK.It has also been authorised to support glycaemic control in p…
https://www.shemed.co.uk/blog/weight-loss/what-is-orforglipr…
check_circle
Claim 6: “The UK is the first country in Europe to approve it, after approving another weight-loss pill in June.”
CORROBORATED
GOV.UK explicitly states the UK is the first country in Europe to approve it. Other sources confirm the approval of a different weight-loss pill (a tablet form of Wegovy) in June.
menu_book
wikipedia NEUTRAL — Orforglipron, sold under the brand name Foundayo, is an oral, non-peptide, small-molecule GLP-1 receptor agonist developed as a weight loss drug by Eli Lilly and Company. It was discovered by Chugai P…
https://en.wikipedia.org/wiki/Orforglipron
travel_explore
web search NEUTRAL — UK Becomes First Country in Europe to Approve New GLP-1 Weight Loss Pill.Eli Lilly launches Foundayo weight-loss pill in the U.K. 6 hours ago.
https://news.google.com/stories/CAAqNggKIjBDQklTSGpvSmMzUnZj…
travel_explore
web search NEUTRAL — The UK became the first European country to offer Eli Lilly's weight-loss and diabetes pill Foundayo via private prescription after MHRA approval on August 10, 2026.
https://evrimagaci.org/gpt/eli-lilly-launches-foundayo-weigh…
+ 1 more evidence source
check_circle
Claim 7: “Eli Lilly saying it is working with the National Institute for Health and Care Excellence (Nice) on its assessment of Foundayo for a potential rollout on the health service in England.”
CORROBORATED
Healthcare Digital and The Independent both report that Eli Lilly is working with NICE to assess the drug for potential NHS rollout in England.
travel_explore
web search NEUTRAL — Eli Lilly/Handout via REUTERS/File Photo. Eli Lilly has launched its pill, Foundayo, in the UK for weight management and type 2 diabetes, it said today, making Britain the first country in Europe wher…
https://www.rte.ie/news/business/2026/0824/1588999-eli-lilly…
travel_explore
web search NEUTRAL — Eli Lilly said it is also working with the National Institute for Health and Care Excellence (NICE) as it assesses Foundayo for potential use on the NHS in England.
https://healthcare-digital.com/news/eli-lillys-foundayo-laun…
travel_explore
web search NEUTRAL — Pharmacy leaders highlighted its importance for patients unable or unwilling to take injectable weight loss treatments, while warning against counterfeit pills. Eli Lilly is working with NHS spending …
https://www.independent.co.uk/bulletin/news/foundayo-eli-lil…
check_circle
Claim 8: “A new daily pill that treats diabetes and helps with weight loss will be available in UK pharmacies from Monday.”
CORROBORATED
Multiple independent sources (Express.co.uk, The Independent, and other web results) confirm that a new daily pill for diabetes and weight loss (Foundayo) became available in UK pharmacies starting Monday.
travel_explore
web search NEUTRAL — A new daily pill for people with diabetes and weight-related conditions has been available in UK pharmacies from Monday.
https://www.express.co.uk/news/uk/2241881/uk-pharmacies-stoc…
travel_explore
web search NEUTRAL — A new daily pill that treats diabetes and helps with weight loss will be available in UK pharmacies from Monday. Pharmacists said the move would be.The MHRA approved the first GLP-1 pill for weight lo…
https://www.surveillanceghana.com/daily-diabetes-and-weight-…
travel_explore
web search NEUTRAL — New daily diabetes pill that helps with weight loss launches in UK pharmacies. 4 hours ago.
https://news.google.com/stories/CAAqNggKIjBDQklTSGpvSmMzUnZj…
help
Claim 9: “Eli Lilly is suing various suppliers it accuses of participating in an illegal hidden market for its drugs.”
INSUFFICIENT EVIDENCE
No evidence was found in the provided search results to support or refute the claim that Eli Lilly is suing suppliers regarding an illegal hidden market.
schedule
Claim 10: “The MHRA approved the first GLP-1 pill for weight loss, a tablet form of Wegovy, in June.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
check_circle
Claim 11: “The pill is taken once a day, at any time, with no food or water restrictions.”
CORROBORATED
The Independent and Heally confirm the pill is taken once daily with no food or water restrictions, specifically contrasting it with the Wegovy pill.
travel_explore
web search NEUTRAL — Foundayo™ is Eli Lilly's new once-daily GLP-1 pill for weight loss — no food or water restrictions required. Get a prescription online through Found's obesity medicine providers.
https://joinfound.com/medication/foundayo
travel_explore
web search NEUTRAL — Taking Foundayo™ (orforglipron). true. Once-daily Foundayo has been proven to help adults with obesity, or some adults with overweight and weight-related medical problems, to lose excess body weight a…
https://foundayo.lilly.com/how-to-take
travel_explore
web search NEUTRAL — Foundayo has no food or timing restrictions; Wegovy pill requires an empty stomach and 30-minute fast each morning. Wegovy pill holds an FDA-approved cardiovascular outcomes benefit; Foundayo does not…
https://getheally.com/patients/news/foundayo-vs-wegovy-pill-…
info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.